Replies to post #109274 on Regen BioPharma Inc (RGBP)

[Musical Shares]

This is pretty much off base.

The IND is for TCellVax (which was already under an IND).

TCellVax didn't make it to phase 1 not because of missing mRNA but because there was nothing to bring to phase 1.

Stop and think for a second.... Why didn't it go to phase 1 when it first received an IND in 2016? For not having "mRNA" for "easier administration?"

mRNA missing isn't going to make it go to phase 1. It has nothing to do with what TCellVax is functionally (physiologically).

But I hope people keep waiting on phase 1.

Koos certainly knows what he is doing. mRNA is a hot topic.

After all, Regen has brought how many drugs to phase 1 from it's inception in 2012?

NONE.

He can't/won't hire a CSO. But he's going to have a drug in phase 1 clinical trials? By himself? LOL